For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Viacyte, Inc.

USPTO Granted Patents = 109

CIPO Patents = 13

EPO Patents = 33

Trademarks = 3

Forward Citations = 1,831

Loading Chart...

Loading Chart...

42 inventors (with patents filed for the assignee):

Chad Green (42 out of 42 patents)

Kevin Allen D'Amour (39 out of 46 patents)

Laura A Martinson (38 out of 42 patents)

4. Emmanuel Edward Baetge (38 out of 46 patents)

5. Alan D Agulnick (34 out of 38 patents)

6. Michael J Scott (24 out of 45 patents)

7. Thomas C Schulz (22 out of 23 patents)

8. Evert Kroon (20 out of 22 patents)

9. Allan J Robins (19 out of 23 patents)

10. Vincent So (18 out of 21 patents)

11. Olivia Kelly (13 out of 14 patents)

12. Susan Eliazer (11 out of 12 patents)

13. Anne Bang (10 out of 11 patents)

14. Erik D Olson (8 out of 19 patents)

15. Giacomo Strollo (7 out of 12 patents)

Core Competencies:

Cell Encapsulation

Pluripotent Stem Cells

Pancreatic Endoderm

Implantable Devices

Human Serum Media

Cryopreservation Techniques

Endocrine Cells

PDX1-Positive Cells

Pancreatic Hormones

Universal Donor Cells

In Vitro Differentiation

3D Cell Culture

109 patents: Sort by Forward Citations

1. 12383670 - Instruments and methods for loading cells into implantable devices (2025-08-12),

2. 12310830 - Biocompatible membrane composite (2025-05-27),

3. 12296125 - 3-dimensional large capacity cell encapsulation device assembly (2025-05-13),

4. 12234477 - Scalable primate pluripotent stem cell aggregate suspension culture (2025-02-25),

5. 12173323 - Methods of using PDX1-positive pancreatic endoderm cells and endocrine precursor cells (2024-12-24),

6. 12144908 - PDX1 pancreatic endoderm cells in cell delivery devices and methods thereof (2024-11-19),

7. 11925488 - Tools and instruments for use with implantable encapsulation devices (2024-03-12),

8. 11920154 - Methods and compositions for feeder-free pluripotent stem cell media containing human serum (2024-03-05),

9. 11905530 - Cell encapsulation device comprising a pancreatic progenitor cell population (2024-02-20),

10. 11904001 - Universal donor cells and related methods (2024-02-20),

11. 11896622 - Methods of producing pancreatic hormones (2024-02-13),

12. 11746323 - PDX1 positive foregut endoderm cells and methods of production (2023-09-05),

13. 11667889 - Methods of making human primitive ectoderm cells (2023-06-06),

14. 11660377 - Cryopreserved in vitro cell culture of human pancreatic progenitor cells (2023-05-30),

15. 11642455 - Instruments and methods for loading cells into implantable devices (2023-05-09),

ViaCyte, Inc. is a regenerative medicine company focused on developing a functional cure for diabetes. The company's innovative approach involves the use of cell replacement therapy to provide long-term insulin independence for people with Type 1 and Type 2 diabetes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

109 Patents

#57 in San Diego, CA

#783 in California

#3,378 in US

#7,010 in the World

San Diego, CA, United States of America

Viacyte, Inc.

Forward Citations = 1,831

42 inventors:

Chad Green (42 out of 42 patents)

Kevin Allen D'Amour (39 out of 46 patents)

Laura A Martinson (38 out of 42 patents)

4. Emmanuel Edward Baetge (38 out of 46 patents)

5. Alan D Agulnick (34 out of 38 patents)

Please report any incorrect information to support@idiyas.com

Loading…